First Time Loading...

Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 5.29 USD 1.54% Market Closed
Updated: May 29, 2024

Aurinia Pharmaceuticals Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aurinia Pharmaceuticals Inc
PP&E Net Peer Comparison

Comparables:
ZYME
TH
RPTX
FUSN
EDT

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
PP&E Net
$112m
CAGR 3-Years
120%
CAGR 5-Years
209%
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
PP&E Net
$37.5m
CAGR 3-Years
29%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
PP&E Net
$1.8m
CAGR 3-Years
-18%
CAGR 5-Years
18%
CAGR 10-Years
25%
Repare Therapeutics Inc
NASDAQ:RPTX
PP&E Net
$7.5m
CAGR 3-Years
-4%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
PP&E Net
$23.9m
CAGR 3-Years
129%
CAGR 5-Years
85%
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
PP&E Net
CA$850k
CAGR 3-Years
-11%
CAGR 5-Years
-6%
CAGR 10-Years
4%

See Also

What is Aurinia Pharmaceuticals Inc's PP&E Net?
PP&E Net
112m USD

Based on the financial report for Mar 31, 2024, Aurinia Pharmaceuticals Inc's PP&E Net amounts to 112m USD.

What is Aurinia Pharmaceuticals Inc's PP&E Net growth rate?
PP&E Net CAGR 5Y
209%

Over the last year, the PP&E Net growth was 1 187%. The average annual PP&E Net growth rates for Aurinia Pharmaceuticals Inc have been 120% over the past three years , 209% over the past five years .